相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vivo Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection
Wang Hengzhuang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The metabolically active subpopulation in Pseudomonas aeruginosa biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms
Wen-Chi Chiang et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2012)
The roles of biofilm matrix polysaccharide Psl in mucoid Pseudomonas aeruginosa biofilms
Luyan Ma et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2012)
Heterogeneity in Pseudomonas aeruginosa Biofilms Includes Expression of Ribosome Hibernation Factors in the Antibiotic-Tolerant Subpopulation and Hypoxia-Induced Stress Response in the Metabolically Active Population
Kerry S. Williamson et al.
JOURNAL OF BACTERIOLOGY (2012)
Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis
Nicole Mayer-Hamblett et al.
PEDIATRIC PULMONOLOGY (2012)
Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols
Giovanni Taccetti et al.
THORAX (2012)
Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis with Pseudomonas aeruginosa
David E. Geller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pseudomonas aeruginosa Population Diversity and Turnover in Cystic Fibrosis Chronic Infections
Eilidh Mowat et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Dynamics of Mutator and Antibiotic-Resistant Populations in a Pharmacokinetic/Pharmacodynamic Model of Pseudomonas aeruginosa Biofilm Treatment
Maria D. Macia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Antagonistic Interactions of Pseudomonas aeruginosa Antibiotic Resistance Mechanisms in Planktonic but Not Biofilm Growth
Xavier Mulet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem on Mucoid and Nonmucoid Pseudomonas aeruginosa Biofilms
Wang Hengzhuang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients
Baoleri Lee et al.
APMIS (2011)
Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
Niels Hoiby
BMC MEDICINE (2011)
Development of antibiotic resistance and up-regulation of the antimutator gene pfpI in mutator Pseudomonas aeruginosa due to inactivation of two DNA oxidative repair genes (mutY, mutM)
Lotte Frigaard Mandsberg et al.
FEMS MICROBIOLOGY LETTERS (2011)
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
C. E. Wainwright et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Evolutionary dynamics of bacteria in a human host environment
Lei Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts
Martin Holm Rau et al.
ENVIRONMENTAL MICROBIOLOGY (2010)
Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies
Daniel J. Hassett et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Antibiotic resistance of bacterial biofilms
Niels Hoiby et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Colistin-Tobramycin Combinations Are Superior to Monotherapy Concerning the Killing of Biofilm Pseudomonas aeruginosa
Gloria Herrmann et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants
Oana Ciofu et al.
MICROBIOLOGY-SGM (2010)
Inhalable Antibiotic Delivery Using a Dry Powder Co-delivering Recombinant Deoxyribonuclease and Ciprofloxacin for Treatment of Cystic Fibrosis
Yan Yang et al.
PHARMACEUTICAL RESEARCH (2010)
Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis
M. Kolpen et al.
THORAX (2010)
Antibiotic Resistance in Pseudomonas aeruginosa Strains with Increased Mutation Frequency Due to Inactivation of the DNA Oxidative Repair System
L. F. Mandsberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
S. Islam et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review
Felix Ratjen et al.
JOURNAL OF CYSTIC FIBROSIS (2009)
Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus
Harry Heijerman et al.
JOURNAL OF CYSTIC FIBROSIS (2009)
Role of Mutation in Pseudomonas aeruginosa Biofilm Development
Tim C. R. Conibear et al.
PLOS ONE (2009)
Pseudomonas aeruginosa Biofilms in the Respiratory Tract of Cystic Fibrosis Patients
Thomas Bjarnsholt et al.
PEDIATRIC PULMONOLOGY (2009)
Inactivation of Efflux Pumps Abolishes Bacterial Biofilm Formation
Malin Kvist et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2008)
Increased mutability of Pseudomonas aeruginosa in biofilms
K. Driffield et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients
Helle Krogh Johansen et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience
C. R. Hansen et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes
Suenje Johanna Pamp et al.
MOLECULAR MICROBIOLOGY (2008)
Endogenous oxidative stress produces diversity and adaptability in biofilm communities
Blaise R. Boles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections
Lei Yang et al.
JOURNAL OF BACTERIOLOGY (2008)
Sputum antibiotic concentrations: Implications for treatment of cystic fibrosis lung infection
T. F. Moriarty et al.
PEDIATRIC PULMONOLOGY (2007)
A common mechanism of cellular death induced by bactericidal antibiotics
Michael A. Kohanski et al.
CELL (2007)
Differentiation and distribution of colistin- and sodium dodecyl sulfate-tolerant cells in Pseudomonas aeruginosa biofilms
Janus A. J. Haagensen et al.
JOURNAL OF BACTERIOLOGY (2007)
Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa
MD Maciá et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Pharmacokinetics of inhaled colistin in patients with cystic fibrosis
F Ratjen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis
B Lee et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions
D Hill et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients
G Taccetti et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms
RJ Gillis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Aminoglycoside antibiotics induce bacterial biofilm formation
LR Hoffman et al.
NATURE (2005)
Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections
MD Maciá et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation
O Ciofu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent
T Bjarnsholt et al.
MICROBIOLOGY-SGM (2005)
Survival strategies of infectious biofilms
CA Fux et al.
TRENDS IN MICROBIOLOGY (2005)
Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and β-lactamase and alginate production
N Bagge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vivo pharmacodynamic activity of daptomycin
N Safdar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis
SM Moskowitz et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Azithromycin in, patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa -: A randomized controlled trial
L Saiman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: Evidence from 20 adult patients with signs of maldevelopment of the testis
NE Skakkebaek et al.
APMIS (2003)
Characterization of the GO system of Pseudomonas aeruginosa
A Oliver et al.
FEMS MICROBIOLOGY LETTERS (2002)
Constitutive high expression of chromosomal β-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD
N Bagge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Extracellular DNA required for bacterial biofilm formation
CB Whitchurch et al.
SCIENCE (2002)
Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function
M Hentzer et al.
JOURNAL OF BACTERIOLOGY (2001)
Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients:: antibiotic resistance, β-lactamase activity and RiboPrinting
O Ciofu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Multidrug efflux pumps:: Expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms
TR De Kievit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Role of alginate and its O acetylation in formation of Pseudomonas aeruginosa microcolonies and biofilms
DE Nivens et al.
JOURNAL OF BACTERIOLOGY (2001)
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
A Oliver et al.
SCIENCE (2000)
Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa
O Ciofu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
S Jalal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
